These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

204 related items for PubMed ID: 15311727

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Tolerability and safety of frovatriptan with short- and long-term use for treatment of migraine and in comparison with sumatriptan.
    Géraud G, Spierings EL, Keywood C.
    Headache; 2002 Apr; 42 Suppl 2():S93-9. PubMed ID: 12028325
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Safety and tolerability of frovatriptan in the acute treatment of migraine and prevention of menstrual migraine: Results of a new analysis of data from five previously published studies.
    MacGregor EA, Pawsey SP, Campbell JC, Hu X.
    Gend Med; 2010 Apr; 7(2):88-108. PubMed ID: 20435272
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Clinical efficacy of frovatriptan: placebo-controlled studies.
    Ryan R, Géraud G, Goldstein J, Cady R, Keywood C.
    Headache; 2002 Apr; 42 Suppl 2():S84-92. PubMed ID: 12028324
    [Abstract] [Full Text] [Related]

  • 9. A randomized trial of frovatriptan for the intermittent prevention of menstrual migraine.
    Silberstein SD, Elkind AH, Schreiber C, Keywood C.
    Neurology; 2004 Jul 27; 63(2):261-9. PubMed ID: 15277618
    [Abstract] [Full Text] [Related]

  • 10. Clinical and economic comparison of frovatriptan versus other oral triptans in the treatment of acute migraine in the real-world setting.
    Guidotti M, Ravasio R.
    Clin Drug Investig; 2009 Jul 27; 29(11):693-702. PubMed ID: 19813772
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Pharmacokinetic evaluation of frovatriptan.
    Negro A, Lionetto L, Casolla B, Lala N, Simmaco M, Martelletti P.
    Expert Opin Drug Metab Toxicol; 2011 Nov 27; 7(11):1449-58. PubMed ID: 21929465
    [Abstract] [Full Text] [Related]

  • 18. Frovatriptan: a selective type 1B/1D serotonin receptor agonist for the treatment of migraine headache.
    Cole P, Rabasseda X.
    Drugs Today (Barc); 2002 Sep 27; 38(9):615-29. PubMed ID: 12582449
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.